Autism Research Institute
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$6,015,807
Investments
63%
Cash & Equivalents
19%
Receivables (Non-Related)
17%
Other Assets
<1%
Property, Plant, & Equipment (net)
<1%
Related-Party Receivables
0%
Inventories
0%
Prepaid Expenses
0%
Liabilities in 2024 (Year End)
$587,050
Other Liabilities
96%
Payables & Accruals
4%
Grants Payable
0%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$302,380
$1,143,476
+278%
Receivables (Non-Related)
$50,000
$1,044,275
+1989%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$26,906
-
-
Investments
$4,345,041
$3,812,505
-12%
Property, Plant, & Equipment (net)
$6,453
$5,551
-14%
Other Assets
$10,000
$10,000
+0%
Total Assets
$4,740,780
$6,015,807
+27%
Liabilities
2023
2024
Change
Payables & Accruals
$12,759
$24,630
+93%
Grants Payable
-
-
-
Deferred Revenue
-
-
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
$51,951
$562,420
+983%
Total Liabilities
$64,710
$587,050
+807%
Net assets
2023
2024
Change
Restricted Net Assets
$119,240
$10,111
-92%
Unrestricted Net Assets
$4,556,830
$5,418,646
+19%
Net assets
2023
2024
Change
Net assets
+$4,676,070
+$5,428,757
+16%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)